Inventor
VAN DEN BRINK EDWARD NORBERT
NL21 patents
⚠️ This page may combine multiple inventors who share the name “VAN DEN BRINK EDWARD NORBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENMAB AS
12 patentsUS10590206B2Mar 17, 2020
Inert format
GENMAB AS29 citations93
US10407501B2Sep 10, 2019
Humanized or chimeric CD3 antibodies
GENMAB AS15 citations93
US11485796B2Nov 1, 2022
Inert format
GENMAB AS6 citations85
US9657107B2May 23, 2017
Monoclonal antibodies against c-Met
GENMAB AS9 citations84
US10512688B2Dec 24, 2019
Antibodies binding AXL
GENMAB AS4 citations83
US10500276B2Dec 10, 2019
Antibodies binding AXL
GENMAB AS4 citations83
US10201607B2Feb 12, 2019
Antibodies binding AXL
GENMAB AS7 citations83
US11613575B2Mar 28, 2023
Humanized or chimeric CD3 antibodies
GENMAB AS4 citations74
US10765743B2Sep 8, 2020
Antibodies binding AXL
GENMAB AS3 citations72
US12589150B2Mar 31, 2026
Antibodies binding AXL
GENMAB AS0 citations62
US11512140B2Nov 29, 2022
Monoclonal antibodies against c-Met
GENMAB AS0 citations62
US9663578B2May 30, 2017
Monoclonal antibodies against CD32b
GENMAB AS1 citations49
VAN DEN BRINK EDWARD NORBERT
4 patentsUS8691223B2Apr 8, 2014
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
VAN DEN BRINK EDWARD NORBERT63 citations97
US8192927B2Jun 5, 2012
Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof
VAN DEN BRINK EDWARD NORBERT53 citations97
US8802089B2Aug 12, 2014
Monoclonal antibodies against CD32B
VAN DEN BRINK EDWARD NORBERT7 citations80
US9011848B2Apr 21, 2015
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
VAN DEN BRINK EDWARD NORBERT0 citations51